These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14529455)

  • 1. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences.
    Butterfield DA
    Curr Med Chem; 2003 Dec; 10(24):2651-9. PubMed ID: 14529455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
    Yatin SM; Varadarajan S; Link CD; Butterfield DA
    Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
    Butterfield DA; Kanski J
    Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain.
    Butterfield DA; Boyd-Kimball D
    Brain Pathol; 2004 Oct; 14(4):426-32. PubMed ID: 15605990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal weapon: amyloid beta-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease.
    Lahiri DK; Greig NH
    Neurobiol Aging; 2004; 25(5):581-7. PubMed ID: 15172733
    [No Abstract]   [Full Text] [Related]  

  • 12. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.
    Varadarajan S; Yatin S; Kanski J; Jahanshahi F; Butterfield DA
    Brain Res Bull; 1999 Sep; 50(2):133-41. PubMed ID: 10535332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
    Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Hara H; Ohashi R; Takegoshi K; Fukuda H; Nagao M; Shimizu T; Shirasawa T
    Mini Rev Med Chem; 2007 Oct; 7(10):1001-8. PubMed ID: 17979802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
    Butterfield DA; Howard B; Yatin S; Koppal T; Drake J; Hensley K; Aksenov M; Aksenova M; Subramaniam R; Varadarajan S; Harris-White ME; Pedigo NW; Carney JM
    Life Sci; 1999; 65(18-19):1883-92. PubMed ID: 10576432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
    Butterfield DA; Boyd-Kimball D
    Biochim Biophys Acta; 2005 Jan; 1703(2):149-56. PubMed ID: 15680223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).
    Varadarajan S; Kanski J; Aksenova M; Lauderback C; Butterfield DA
    J Am Chem Soc; 2001 Jun; 123(24):5625-31. PubMed ID: 11403592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
    Yatin SM; Aksenov M; Butterfield DA
    Neurochem Res; 1999 Mar; 24(3):427-35. PubMed ID: 10215518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.